Drug Trial Radar · NCT06865079
53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
Last checked: Nov 19, 2026Latest source record: Feb 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
May 9, 2025
Primary completion
Mar 25, 2027
Study completion Apr 15, 2027
Sponsor
- Lead sponsor
- OrthoTrophix, IncIndustry
- Sponsor type
- Industry
- First posted
- Mar 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
Conditions
- Osteoarthritis (OA) of the Knee
Interventions
TPX-100 200mg, Once weekly for 4 weeksDrug
TPX-100 (200 mg per dose) will be administered once-weekly (Week 1, 2, 3 \& 4) to a single target knee of the subject for 4 injections. TPX-100 can be administered by conventional methods such as subcutaneous or intra-articular injection.
PBSOther
PBS / placebo for intra-articular injection administered once-weekly (Week 1, 2, 3 and 4) to a single target knee of the subject for 4 injections
Primary outcomes
What the sponsor says the trial is designed to measure.
- Toxicity Reaction (CTC 5.0 standard)Time frame: Baseline to Study Week 27 and Study Week 53
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Elite Clinical Network
Scottsdale, Arizona
Noble Clinical Research
Tucson, Arizona
Legent Orthopedic Hospital
Carrolton, California
Medvin Clinical Research
Covina, California
CORE Orthopaedic Medical Center
Encinitas, California
Marvel Clinical Research (Elite Clinical Network)
Huntington Beach, California
Medvin Clinical Research Center
Riverside, California
Medvin Clinical Research Center
Tujunga, California
Medvin Clinical Research Center
Whittier, California
K2 Medical Research
Maitland, Florida
Wellness Research Center
Miami, Florida
Well Pharma Medical Research
Miami, Florida
Las Mercedes Medical Research
Miami, Florida
Drug Studies of America
Marietta, Georgia
AMR Kansas City
Kansas City, Kansas
University of Kansas Medical Center
Kansas City, Kansas
AMR Lexington
Lexington, Kentucky
Accurate Clinical Research Inc.
Lake Charles, Louisiana
Mayo Clinic (Rochester)
Rochester, Minnesota
Las Vegas Clinical Trials
North Las Vegas, Nevada
Albuquerque Clinical Trials
Albuquerque, New Mexico
Center for Clinical Research
Winston-Salem, North Carolina
Hightower Clinical
Oklahoma City, Oklahoma
University Orthopedics Center
Altoona, Pennsylvania
University Orthopedics Center
State College, Pennsylvania
AMR Knoxville
Knoxville, Tennessee
Accurate Clinical Research, LLC
Baytown, Texas
Texas Orthopedic Specialist
Bedford, Texas
First Surgical Hospital
Bellaire, Texas
Accurate Clinical Research
Houston, Texas
Endeavor Clinical Trials
San Antonio, Texas
CenExel
Salt Lake City, Utah
Wasatch Clinical Research
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.